Location History:
- Pittsburgh, PA (US) (1995 - 2018)
- Charlottesville, VA (US) (2019)
Company Filing History:
15 out of 1,863 
3 out of 998 
Years Active: 1995-2025
Title: The Innovative Contributions of John S. Lazo
Introduction
John S. Lazo is a prominent inventor based in Pittsburgh, PA, known for his significant contributions to the field of pharmaceutical sciences. With a total of 15 patents to his name, Lazo has made remarkable strides in developing compounds that target critical biological processes.
Latest Patents
Among his latest patents is the invention titled "In-flow photooxygenation of aminothienopyridinones generates novel PTP4A3 phosphatase inhibitors." This patent discloses compounds that inhibit protein tyrosine phosphatase, specifically protein tyrosine phosphatase 4 A3 (PTP4A3). The invention also includes pharmaceutical compositions, uses, and methods for utilizing these compounds in cancer treatment. Another similar patent, "In-flow photooxygenation of aminothienopyridinones generates PTP4A3 phosphatase inhibitors," further emphasizes the potential of these compounds in therapeutic applications.
Career Highlights
Lazo has had a distinguished career, working at esteemed institutions such as the University of Pittsburgh and the University of Virginia. His research has focused on the development of innovative therapeutic agents, particularly in the realm of cancer treatment.
Collaborations
Throughout his career, Lazo has collaborated with notable colleagues, including Peter Wipf and Robert L. Rice. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
John S. Lazo's work exemplifies the spirit of innovation in the pharmaceutical field. His contributions, particularly in developing PTP4A3 phosphatase inhibitors, highlight the potential for new cancer treatments. His career reflects a commitment to advancing medical science through inventive solutions.